COST EFFECTIVENESS OF ICATIBANT FOR HEREDITARY ANGIOEDEMA IN BRAZIL- CHALLENGES IN THE ECONOMIC EVALUATION OF ORPHAN DRUGS
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1066
https://www.valueinhealthjournal.com/article/S1098-3015(16)01134-7/fulltext
Title :
COST EFFECTIVENESS OF ICATIBANT FOR HEREDITARY ANGIOEDEMA IN BRAZIL- CHALLENGES IN THE ECONOMIC EVALUATION OF ORPHAN DRUGS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01134-7&doi=10.1016/j.jval.2016.03.1066
First page :
A248
Section Title :
Systemic Disorders/Conditions - Cost Studies
Open access? :
No
Section Order :
913